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Drug resistant bacterial pathogens are increasing in the environment due to 
multiple reasons. If any drug resistant pathogen grows in a host, the host will 
face death treat because there is no way to resist their growth in the host 
system. Eventuality is death in almost all cases. Reports on the mechanisms 
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of drug resistance in bacteria are many. However, there is no solution for 
these cases. The present work is providing an important understanding to 
fight against drug resistant pathogens and that can be used in gastrointestinal 
diseases.
____________________________________________________________
 Introduction 
 The use of toxic chemicals is common to encounter with the problems of 
insects, pests and pathogens of various kinds. We use drugs of various kinds 
to treat bacterial, viral and fungal diseases. Bacterial diseases are many types 
and to treat these diseases we use various antibiotics. Antibiotic research is 
generated  from  the  period  of  Fleming  (1928)  and  until  now  various 
antibiotics are used as major life saving drugs ( Majumder and Bose ,1958, 
Storm et al.1977,Hara et al 1983,Champness, 1988, Champness et al ,1992, 
Bibb,  1996,  Sen,2007).  However,  increase  of  environmental  pollution, 
misuse of antibiotics during therapy  are the major reasons of generation of 
drug resistant disease causing organisms in the environment  ( Neu. 1992, 
Hiramitsu  et  al.,  1997,  McGowan,2001,Chambers,2001,   Carpenter  and 
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Chambers 2004,Kang et al., 2005,  Li and Nicadio, 2009,Lee et al. 2010). 
Importantly,  the disease due to drug resistant  bacteria  is  very difficult  to 
cure. Therefore, death of a patient is the immediate consequence for almost 
in very cases. In this work, experiments are carried out to encounter with a 
drug resistant organism. A novel avenue of study is developed in vitro that 
can be used to encounter with drug resistant intestinal pathogens.
Material :  The bacterium, E.coli cell harboring  the plasmid pBR322 was 
used  in  this  study.  Tryptone  ,  beef  extract,  NaCl,  were  from  Difco  co 
,Detroid, USA, ampicillin, tetracycline were from the Sigma co. St.Louis , 
USA, Other materials which were used in this study were from the local 
chemical companies ( Labco., Co. Private, Ltd, Burdwan,  and Dayamoyee 
Chemical Co. Private Ltd. Durgapur, West Bengal, India.) . 
Medium: Luria broth was used to grow the bacterium. 100 ml of medium 
was made with 1.0 g of tryptone, 0.5 g of beef extract, 0.5 g of NaCl, in 
distilled water. The pH of the medium is adjusted to 7.0 with the addition of 
requisite amount of  0.5 N NaOH or 0.5N HCl . The medium was sterilized 
by autoclaving at 121oC for 15 min. at 15 lbs/ inch 2. The Petri plates were 
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prepared using Luria broth containing 1.5% or 2.0% agar agar. This medium 
was used in many experiments. All experiments taking bacterial cells were 
carried out using either solid or liquid medium. 
Isolation of bacteriophage: Bacteriophages of various types were isolated 
following infection of  E. coli  host cell harboring pBR322. Host cells were 
grown for 6 hrs at 370C. O.5ml of host cells was mixed with 0.2 ml of waste 
water. The cells were then mixed with 3.5ml of soft agar and poured on to a 
hard agar plate containing 2.0 % agar agar.  The plates were incubated at 
37oC for 36 hrs .
Isolation of Amoeba sp : The Amoeba sp was isolated by incubating 9.5 ml 
of Luria broth containing 0.5 ml of overnight grown bacterial cells and 0.5 
ml of pond water . The culture tube was incubated al 37oC . The shaking 
was avoided for first 12 hrs of incubation and then cells were incubated with 
mild shaking at 80 to 100 rpm. The cells were incubated for 48 hrs . This 
culture was used as the stock of Amoeba sp.
Killing of bacterial cells using Amoeba sp.: A Petri plate containing Luria 
agar medium was used to spread E.coli HB101 harboring pBR322. The plate 
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was incubated for 16 hrs at 37oC . It was then taken out from the incubator 
and a drop of amoeba culture was added on the surface of the Petri plate. 
The plate was incubated at 37oC for several hrs. In another Petri plate the 
host bacterium and the amoeba culture was layered using soft agar medium 
as per the method used to plate bacteriophages. The plate was incubated for 
24 to 36 hrs. 
Results:
Isolation of bacteriophage using E.coli host cell harboring pBR322:
The E.coli HB101 strain is used in this experiment. The host is transformed 
with  pBR322  and  selected  in  Luria  agar  plates  containing  35 g/ml 
ampicillin and 10µg /ml tetracycline. The selected bacterial colony is then 
grown in Luria broth containing the same antibiotics. The host cells is then 
mixed with sewage water and plated in hard agar plates mixing with soft 
agar.  The  plates  after  incubation  at  37oC  shows  multiple  clear  zones 
indicating presence of virulent bacteriophages in the sewage water. One of 
the plaque was selected for further work. The plaque was amplified in Luria 
broth containing the same host cells. The amplified phage stock was used in 
5
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
10
.4
93
4.
1 
: P
os
te
d 
25
 S
ep
 2
01
0
various experiments. The bacterium is then grown in 10 ml of Luria broth 
with 1.0 ml of fresh host cells and 0.1ml of phage stock . A control set was 
also made where no bacteriophage was added. The experiment is conducted 
for 48 hrs in mild shaking conditions. It shows reduction of optical density 
of the host cells. It was 0.89 for control set and in the experimental set it was 
0.38 at 540nm. Therefore it indicates lysis of host cells and it occurred due 
to lysis of bacterial cells in the culture broth. The killing of the host cells are 
tested by plating the lysed cells in a fresh agar plates . It shows presence of 
viable  cells  in  the  set  treated  with  the  bacteriophage.  The  figure  shows 
(Fig.1B) plaques in the bacterial  lawn. However,  the number  of plaques 
were variable in various Petri plates.  Therefore, a drug resistant host can be 
killed  using  the  bacteriophage.  Moreover,  lysis  of  all  host  cells  is  not 
possible in the experimental conditions followed in this study. 
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 Fig. 1.              A. B.
Fig.1. Use of  E.coli host haboring the plasmid pBR322 and cellular lysis 
using bacteriophage isolated from sewage.
A. The plasmid pBR322 , it shows the drug resistant sites, ampicillin  in 
orange  color  and tetracycline  in  pink color.  B.  A Petri  plates  containing 
E.coli bacterial host harboring the plasmid and lysis of the host due to phage 
infection and propagation.
Isolation  of  Amoeba  sp.  from  pond  water  and  killing  of  the  drug 
resistant bacterial host: To isolate amoeba the bacterial host cell harboring 
the  plasmid  pBR322  is  used  .  The  bacterium  is  therefore  resistant  to 
tetracycline and ampicillin. 10 ml of bacterial culture is incubated with 0.5 
ml of pond water. The water samples are collected from various fresh water 
reservoirs. The culture tubes were incubated for five days at 37oC in mild 
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shaking condition. The shaking speed was 100 rpm. The culture tubes were 
taken  out  in  every  24  hrs  of  incubation  and  visual  observation  was 
conducted by viewing turbidity against a light dark field. In many tubes it 
showed reduction of turbidity. These tubes were separated from the lot of 
tubes where turbidity was less.  Seven such culture tubes are selected . The 
tubes are kept at 4.0  0C for further study. Bacterial lawn was prepared in 
agar plated taking the host cells. In the lawn of the bacterial culture a drop of 
amoeba culture was added. It  plate was incubated at 370C for 24 hrs . It 
showed clear zones around the drop of the selected co-culture of bacteria 
and amoeba. The plate was incubated for 18 hrs at 370C. It showed complete 
clearance  of  bacterial  lawn.  The  figure  shows  (Fig.2B)  the  killing  of 
bacterial host on the Petri plate. Importantly, the clearance of bacterial lawn 
was fast in many cases. The Amoeba culture that showed highest clearance 
with in short period is selected for further study. 
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Fig. 2           A. B.
Fig.2.  Food  vacuole  formation  by  amoeba  sp.  and  zone  of  clearance  of 
bacterial lawn due to growth of amoeba isolated from pond water.
A. An amoeba cell with its cellular parts, it shows formation of food vacuole 
by the pseudopodia. B.  E.coli cells and the bacterial lawn inside the Petri 
plate and the zone of clearance .The arrow indicates the clear zone inside the 
bacterial lawn.
Discussion
The generation of drug resistant bacterial pathogens occurs due to multiple 
molecules that are generated in a pathogen due to exposure of the pathogen 
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in a complicated cellular environment ( Carpenter and Chamber, 2004) .The 
process is cascaded with plethora of cellular mechanisms in a  drug resistant 
pathogen ( Neu1992, Noble et al., 1992, Hiramitsu et al ., 1997, Chamber 
2001, Sen, 2002 ). However, it is very difficult to cure a patient infected 
with  drug  resistant  organism  (  Herold  et  al.  1990,  Thomus  etal.  1998, 
Kuijper  et al2007). Bacteriophages of various types can be used to kill a 
drug resistant pathogen (William,2001). An experiment is  conducted with a 
bacterial strain harboring the drug resistant plasmid. The plasmid, pBR322, 
has two drug resistant  genes , ampicillin and tetracycline respectively  and 
this  organism  is  treated  with  bacteriophages  isolated  from  sewage.  The 
results show reduction of optical density to a specific level after incubation 
of  the bacterial  cells  in Luria  broth with the selected bacteriophage.  The 
plating  of  the  broth  produced  colonies  of  bacterial  cells.  It  indicates  the 
presence of viable cells in the phage treated cells. However, it showed clear 
plagues  on  the  plates  containing  E.coli HB101  harboring  the  plasmid 
(Fig.1.B.). It is due to the killing of the organism due to infection of the 
bacteriophage . Importantly, 100% killing is not possible due to generation 
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of phage resistant host which occurs due to multiple cellular molecules that 
are synthesized in bacteriophage immune bacteria.  It is known that Amoeba  
proteus and other nonpathogenic Amoeba sp. use bacterial cell as their food. 
Therefore,  Amoeba   strains  are  isolated  from  fresh  water  to  kill  the 
organism.  Amoeba proteus and other  species of amoeba have phagocytic 
activity similar to macrophages of immune systems of mammals( Goldsby et 
al  ,2001,  Roitt,  Et  al  ,2001,  Abbas  and  Lichtman,  2003).  Mammalian 
macrophages produce phagosomes where a pathogen undergoes degradation 
using  multiple  hydrolytic  enzymes.   The  phagocytic  activity  of  amoeba 
makes food vacuole and the bacterial cells undergo degradation in side the 
cytosol of Amoeba. The plate cultures and broth cultures showed the killing 
of bacterial cells by the amoeba cells. The use of amoeba culture  in vitro 
showed 100% killing with in 24 hrs of incubation at 37oC. Therefore, the 
procedure can be used  to treat gastrointestinal diseases due to the infection 
of  drug resistant  or  drug sensitive pathogen.  The procedure  has multiple 
advantages over the use of antibiotics and chemical compounds that we use 
in therapy.  However,  all  of them are cascaded with multiple side effects. 
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However,  in vivo experiments  using infected higher  animals  and amoeba 
will  provide  essential  clues  to  justify  the  novelty  of  this  technique  in 
therapeutic science.
____________________________________________________________
Acknowledgement:
Thanks to Chairman of Rahul Foundation , Mr. R.N.Majumder for providing 
all facilities to do these experiments. I am thankful to Dr. Shouri Banerjee, 
Principal  ,  DCCS, Rajbandh, Durgapur,  and all  my colleagues at  DCCS. 
Thanks are due to Mr. Tinku Mandal and Ram K. Akhuli for multiple helps 
during this study.
References
1. Abbas,  A.K.  and  Lichtman,  A.H.  Cellular  and  molecular 
immunology,Chapter5,  Antigen  processing  and  presentation  to  T 
lymphocytes, Saunders, pp81-104.
12
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
10
.4
93
4.
1 
: P
os
te
d 
25
 S
ep
 2
01
0
2. Bibb,  M.,  1996,  The  regulation  of  antibiotic  production  in 
Streptomyces coelicolor A3(2). Microbiology,142, 1335-1344.
3. Carpenter,C.F. and Chambers,H.I., 2004, Daptomycin: another novel 
agent  for  treating  infections  due  to  drug  resistant  gram  positive 
pathogens. Clin. Infect. Dis. 38,994-1000.
4. Chambers,  H.I.,2001,  The  changing  edidemology  of  Staptococcous 
aureus ? Emerg. Infect.Dis.7, 178-182.
5. Champness,  W.  C.  1988,  New  loci  required  for  Streptomyces  
coelicolor  morphological  and  physiological  differentiation  . 
J.Bacteriol. 470,1168-1174.
6. Champness,  W.  C.,  Riggle,  P.,  Adamidis,  T.  and  Vamdevare,  P., 
1992,Identification  of  gene  involved in  regulation  of  Streptomyces  
coelicolor antibiotic synthesis.Gene,115,55-60.
7. Goldsby, R.A, Kindt, T.J. Osborne,B.A., and Kuby,J. ,2001,  Chapter 
8: Antigen processing and presentation., W.H. Freeman and Co. New 
York. Pp185-196.
13
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
10
.4
93
4.
1 
: P
os
te
d 
25
 S
ep
 2
01
0
8. Hara,D.,  Horinouchi,S.,  Uozami,  S.  and  Beppu,T.,1983,  Genetic 
analysis  of  a  factor  synthesis  in  Streptomyces  coelicolor.A3(2)  of 
Streptomyces griseus. J.Gen.Microbiol., 129,2939-2944.
9. Herold,  B.  C.,  Immergluck,  L.  C.,  Maronum,  M.  C.  et  al 
.1990,Comminity aquired methicillin resistant Staphylococcus aureus 
in children with no identified pre-disposing risk.  J.Am.Med.Assoc., 
279, 593-598.
10. Hiramitsu,K., Hemaki,H., Ino,J., Yabuta,K.,  and Terover,F.C. ,1997, 
Methicillin  resistant  Staphylococcus  aureus clinical  strain  with 
reduced vancomycin susceptibility.J.Antimicrobial.Chemther.40, 134-
135.
11. Kang,C.I.,  Kim,S.I.,  Park,W.B.  et  al.2005  Blood  stream  infections 
caused by antibiotic resistant  gram negative bacilli;  Rick factor  for 
mortality and impact of in appropriate initial antimicrobial therapy on 
out come antimicrobial agents. Chemother. 49,760-766.
14
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
10
.4
93
4.
1 
: P
os
te
d 
25
 S
ep
 2
01
0
12. Kuijper, E. J., VanDissel, Jr, and Wilcox, M. H. 2007,  Clostridium 
difficile :Changing  epidemiology  and  new  treatment 
options.Curr.Opin.Infect.Dis.20, 376-383.
13. Lee,  H.  H.,  Molla,  M.  N,  Canter,  C.R.  and  Collings,  J.J.,   2010, 
Bacterial  charity  work  leads  to  population  wide  resistance. 
Nature,(U.K.) 467,82-85.
14. Li,  X.  and  Nicadio,  H.,  2009,  Efflux  mediate  drug  resistance  in 
bacteria: an update .Drug,68,1555-1623.
15. Majumder,S.K.  and  Bose,  S.K.  ,1958,  A  new  antifungal  antibiotic 
produce by Bacillus subtilis, Nature, 181, 134-135.
16. McGowan,  J.F.  Jr.  2001,  Economic  impact  of  antimicrobial 
resistance. Emerg. Infect.Dis.7,266-292.
17. Neu, H.C. 1992, The crisis in antibiotic resistance. Science (U.S.A.), 
257,1064-1073.
18. Noble, H.C., Vivew, Z., Cree,  and R.G. 1992, Cotransformation of 
vancomycin  and other  resistance  genes  from  Enterococcus faecalis 
15
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
10
.4
93
4.
1 
: P
os
te
d 
25
 S
ep
 2
01
0
NCTC  12201  to  Staphylococcus  aureus.  FEMS  Microbial  lett 
.93,195-198.
19. Roitt,  I.,  Brostuff,  J.  and Male, D.  2001, Immunology, Chapter  6: 
Antigen presentation, Mosby, pp105-115.
20.  Sen,S. 2005, Microbiology, Chemotherapy and antibiotics, Chapter 
V11,  Technoworld, Kolkata, India pp107-130.
21. Sen,  S.  2002,  Legacy  of  international  health  care:  Drug 
resistance,drug development and therapeutic status. Sci. Cult., 68, 45-
55.
22. Storm, D.R., Rosenthal,K.S. and Swanson,P.E.,1977, Polymyxin and 
related peptide antibiotics. Annu. Rev. Biochem.46,723-763.
23. Thomas,  J.  K.,  Forrent,  A.,  Bhanam,  S.  M.  et  al.  1998, 
Pharmacodynamic  evaluation  of  factor  associated  with  the 
development  of  bacterial  resistance  in  acutely  ill  patients  during 
therapy. Antimicrob. Agents. Chemother. 42, 521-527.
24. Willium,W.C.  2001,  Bacteriophage  therapy,  Annu.  Rev. 
Microbiology, 53, 457-551.
16
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
10
.4
93
4.
1 
: P
os
te
d 
25
 S
ep
 2
01
0
17
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
10
.4
93
4.
1 
: P
os
te
d 
25
 S
ep
 2
01
0
